Profusa (PFSA) Free Cash Flow (2022 - 2026)
Profusa's (PFSA) quarterly Free Cash Flow came in at -$2.6 million in Q1 2026, down 394.4% year-on-year from $900126.7 in Q1 2025, and up 47.8% quarter-over-quarter from -$5.1 million in Q4 2025.
Profusa (PFSA) Free Cash Flow (2022 - 2026) Analysis & Trends
Profusa's Free Cash Flow history runs 5 years deep, the most recent figure standing at -$2.6 million for Q1 2026.
- On a quarterly basis, Free Cash Flow fell 394.4% year-over-year to -$2.6 million in Q1 2026; TTM through Mar 2026 was -$18.3 million, a 815.38% decrease from a year earlier, with the FY2025 full-year figure at -$16.2 million, down 674.51% from the prior year.
- Free Cash Flow improved to -$2.6 million in Q1 2026 per PFSA's latest filing, from -$5.1 million in the prior quarter.
- Across five years, Free Cash Flow topped out at $83000.0 in Q4 2024 and bottomed at -$10.6 million in Q3 2025.
- The 5-year median for Free Cash Flow is -$345210.0 (2023), against an average of -$1.4 million.
- Across the five-year window, Free Cash Flow jumped 124.04% in 2024 and sank 6216.87% in 2025, its largest moves.
- Year by year, Free Cash Flow stood at -$179348.0 in 2022, then tumbled by 92.48% to -$345210.0 in 2023, then surged by 124.04% to $83000.0 in 2024, then sank by 6216.87% to -$5.1 million in 2025, then surged by 47.8% to -$2.6 million in 2026.
- Per Business Quant, the three latest PFSA Free Cash Flow figures stand at -$2.6 million (Q1 2026), -$5.1 million (Q4 2025), and -$10.6 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 916.00 Mn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 415.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 2.09 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 171.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | -21.10 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 449.00 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 305.56 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 112.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Profusa | 23,566.40 | -351,433.60 | - | -2.65 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.65 Mn |
| Mar 31, 2026 | -2.65 Mn |
| Dec 31, 2025 | -5.08 Mn |
| Dec 31, 2025 | -5.08 Mn |
| Sep 30, 2025 | -10.62 Mn |
| Sep 30, 2025 | -10.62 Mn |
| Jun 30, 2025 | 35,386.00 |
| Jun 30, 2025 | 35,386.00 |
| Mar 31, 2025 | -536,000.00 |
| Mar 31, 2025 | -536,000.00 |
| Dec 31, 2024 | 83,000.00 |
| Dec 31, 2024 | 83,000.00 |
| Sep 30, 2024 | -1.15 Mn |
| Sep 30, 2024 | -1.15 Mn |
| Jun 30, 2024 | -394,878.00 |
| Jun 30, 2024 | -394,878.00 |
| Mar 31, 2024 | -280,853.00 |
| Mar 31, 2024 | -280,853.00 |
| Dec 31, 2023 | -345,210.00 |
| Dec 31, 2023 | -345,210.00 |